Role of antireflux mucosal ablation in “reflux-predominant” refractory gastroesophageal reflux disease: a randomized sham-controlled trial
Year: 2025
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Endoscopy
DOI: 10.1055/a-2740-9297
Institution: Asian Institute of Gastroenterology
Language: English
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415977385
